Cite
HARVARD Citation
Striepe, K. et al. (2017). Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus. Circulation. 136 (12), p. . [Online].